Sonata Jarmalaite

Summary

Affiliation: Vilnius University
Country: Lithuania

Publications

  1. ncbi Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
    Sonata Jarmalaite
    Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland
    Int J Cancer 106:913-8. 2003
  2. ncbi Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
    Arvydas Laurinavicius
    National Center of Pathology, affiliate of Vilnius University Hospital Santariskiu Clinics, P, Baublio 5, LT 08406 Vilnius, Lithuania
    Diagn Pathol 7:27. 2012
  3. ncbi Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
    Aida Laurinaviciene
    Institute of Oncology Vilnius University, Santariskiu 1, LT 08660 Vilnius, Lithuania
    Diagn Pathol 6:87. 2011
  4. ncbi Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer
    Sonata Jarmalaite
    Faculty of Natural Sciences, Vilnius University, Vilnius, Lithuania
    Oncology 75:145-51. 2008
  5. ncbi Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
    Sonata Jarmalaite
    Faculty of Natural Sciences, Vilnius University, Ciurlionio 21, 3101 Vilnius, Lithuania
    J Cancer Res Clin Oncol 136:847-54. 2010
  6. ncbi Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas
    Sonata Jarmalaite
    Vilnius University, Lithuania
    Cancer Genet 204:398-404. 2011
  7. ncbi Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer
    Rasa Sabaliauskaite
    Division of Human Genome Research Centre, Faculty of Natural Sciences, Vilnius University, and National Center of Pathology, Urology Department, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Genes Chromosomes Cancer 51:781-91. 2012
  8. ncbi Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure
    Asta Scesnaite
    Faculty of Natural Sciences, Vilnius University, Ciurlionio 21, LT03101 Vilnius, Lithuania
    Mutagenesis 27:423-9. 2012
  9. ncbi Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer
    Kristina Daniūnaitė
    Vilnius University, Čiurlionio, Lithuania
    Medicina (Kaunas) 47:147-53. 2011
  10. ncbi Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma
    Sebsebe Lemeta
    Biological Mechanisms and Prevention of Work related Diseases, Finnish Institute of Occupational Health, Helsinki, Finland
    J Neuropathol Exp Neurol 66:860-7. 2007

Collaborators

  • Kirsti Husgafvel-Pursiainen
  • Arvydas Laurinavicius
  • Sisko Anttila
  • Fredrik Nyberg
  • Simone Benhamou
  • Rasa Sabaliauskaite
  • Asta Scesnaite
  • Darius Dasevicius
  • Juozas R Lazutka
  • Feliksas Jankevicius
  • Kristina Daniūnaitė
  • Aida Laurinaviciene
  • Sebsebe Lemeta
  • Harriet Wikman
  • Pertti Mutanen
  • Paolo Boffetta
  • Donatas Petroska
  • Valerijus Ostapenko
  • Artūras Berezniakovas
  • Juozas Lazutka
  • Lea Pylkkanen
  • Tom Bohling
  • Maija Wolf
  • Sakari Knuutila
  • Aki Vayrynen
  • Penny Nymark
  • Anne Kallioniemi
  • Katri Vainio-Siukola
  • Kaisa Salmenkivi

Detail Information

Publications11

  1. ncbi Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
    Sonata Jarmalaite
    Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland
    Int J Cancer 106:913-8. 2003
    ..14%; P = 0.035). Taken together, our data suggest that analysis of promoter methylation in TSGs may provide a valuable biomarker for identification of groups with an elevated risk of cancer, such as smokers and ex-smokers...
  2. ncbi Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data
    Arvydas Laurinavicius
    National Center of Pathology, affiliate of Vilnius University Hospital Santariskiu Clinics, P, Baublio 5, LT 08406 Vilnius, Lithuania
    Diagn Pathol 7:27. 2012
    ..Digital image analysis (DA) with multivariate statistics of the data opens new opportunities in this field...
  3. ncbi Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
    Aida Laurinaviciene
    Institute of Oncology Vilnius University, Santariskiu 1, LT 08660 Vilnius, Lithuania
    Diagn Pathol 6:87. 2011
    ....
  4. ncbi Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer
    Sonata Jarmalaite
    Faculty of Natural Sciences, Vilnius University, Vilnius, Lithuania
    Oncology 75:145-51. 2008
    ....
  5. ncbi Promoter hypermethylation in tumour suppressor genes and response to interleukin-2 treatment in bladder cancer: a pilot study
    Sonata Jarmalaite
    Faculty of Natural Sciences, Vilnius University, Ciurlionio 21, 3101 Vilnius, Lithuania
    J Cancer Res Clin Oncol 136:847-54. 2010
    ..In this pilot study we sought to determine the prognostic value of epigenetic and genetic inactivation of tumour suppressor genes (TSGs) among BC patients treated with IL-2...
  6. ncbi Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas
    Sonata Jarmalaite
    Vilnius University, Lithuania
    Cancer Genet 204:398-404. 2011
    ..In conclusion, our study suggests the involvement of the imprinted ZAC gene in the pathogenesis of PCC...
  7. ncbi Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer
    Rasa Sabaliauskaite
    Division of Human Genome Research Centre, Faculty of Natural Sciences, Vilnius University, and National Center of Pathology, Urology Department, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania
    Genes Chromosomes Cancer 51:781-91. 2012
    ..The results of our study suggest that combined analysis of TMPRSS2-ERG and TERT expression can be a valuable tool for early prediction of biochemical recurrence of PCa after radical prostatectomy...
  8. ncbi Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure
    Asta Scesnaite
    Faculty of Natural Sciences, Vilnius University, Ciurlionio 21, LT03101 Vilnius, Lithuania
    Mutagenesis 27:423-9. 2012
    ....
  9. ncbi Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer
    Kristina Daniūnaitė
    Vilnius University, Čiurlionio, Lithuania
    Medicina (Kaunas) 47:147-53. 2011
    ..02). CONCLUSIONS. Results of our study show a high sensitivity of DNA methylation biomarkers, especially RASSF1 and RARB, for the early and noninvasive detection of PCa...
  10. ncbi Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma
    Sebsebe Lemeta
    Biological Mechanisms and Prevention of Work related Diseases, Finnish Institute of Occupational Health, Helsinki, Finland
    J Neuropathol Exp Neurol 66:860-7. 2007
    ..This novel finding highlights the importance of ZAC1 in development of CHB, particularly in non-VHL-associated cases...
  11. ncbi CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer
    Harriet Wikman
    Department of Occupational Medicine, Finnish Institute of Occupational Health, Helsinki, Finland
    Genes Chromosomes Cancer 42:193-9. 2005
    ..Although CDK4 amplification seems to be a relatively rare event (4.3%) in lung tumors, it indicates the significance of the RB1-CCND1 pathway in lung tumorigenesis...